U.S. market Open. Closes in 5 hours 2 minutes

BXRX | Baudax Bio, Inc. Stock Financials Income Statements Annual

(Stock Exchange: NASDAQ)
*Sign In to persist settings
Financial Year End2022-12-312021-12-312020-12-312019-12-312018-12-312017-12-31
Revenue1.27M1.08M493.00KN/AN/AN/A
Cost of Revenue7.01M2.44M1.73MN/AN/AN/A
Gross Profit-5.74M-1.36M-1.24MN/AN/AN/A
Operating Expenses30.00M51.01M54.57M47.07M65.04M48.26M
Selling, General & Admin24.12M45.31M43.34M27.01M29.45M19.63M
Research & Development5.88M3.12M9.09M20.06M35.58M28.64M
Other Operating ExpensesN/A2.58M2.15M-38.00K-132.00K16.00K
Operating Income-35.74M-19.01M-74.79M-32.52M-73.53M-61.10M
Other Expenses / Income-23.05M32.61M-1.31M7.32M-8.63M-12.82M
Before Tax Income-58.80M-19.77M-76.10M-32.56M-73.67M-61.08M
Income Tax ExpensesN/A3.84M1.40M-14.55M-132.00K12.84M
Net Income-58.80M-19.77M-76.10M-18.00M-73.67M-61.08M
Interest Expenses21.07M2.30M1.36MN/AN/AN/A
Basic Shares Outstanding331.62K54.74K13.31K6.68K6.48K6.48K
Diluted Shares Outstanding331.62K54.74K13.31K6.68K6.48K6.48K
EBITDA-35.58M-48.26M-74.79M-39.39M-56.14M-35.35M
EBITDA Margin-2,803.62%-4,468.52%-15,169.57%0.00%0.00%0.00%
EBIT-37.73M-13.62M-73.34M-32.56M-73.80M-48.24M
EBIT Margin-2,972.81%-1,261.39%-14,875.66%0.00%0.00%0.00%
Financial Year End2022-12-312021-12-312020-12-312019-12-312018-12-312017-12-31
An error has occurred. This application may no longer respond until reloaded. Reload 🗙